Home > Keeping pace with the PARP inhibitors: What are the latest data on their role in maintenance treatment for ovarian cancer?

Keeping pace with the PARP inhibitors: What are the latest data on their role in maintenance treatment for ovarian cancer?

Stay abreast of the latest data for PARP inhibitors in the first-line maintenance treatment of advanced ovarian cancer by watching a webinar and interviews with international experts on data from the virtual SGO and ASCO annual meetings 2020.

Congress Activities

IME
CME and Education Activities are developed by touchIME for touchONCOLOGY.

Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.

Copied to clipboard!
accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar